Install
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
- 283,142articles · 365d
- 1+ hour agolatest article
- Sep 13, 2025earliest in window
- 9%with images · 12,383 videos
- 293avg words
- business 172,975
- stocks 118,612
- markets 111,402
- investing 92,532
- stock market 91,206
- business news 75,989
- stock 71,333
- investment 70,394
- stock market news 67,205
- finance 56,899
- technology 54,612
- investment advice 53,957
- companies 49,945
- online trading 49,185
- online investment 43,606
- artificial intelligence 39,104
- online stock trading 37,095
- financial 31,434
- ai 29,687
- inc 20,547
- Economy, Business & Finance 248,814
- Finance & Business 235,635
- News 129,765
- Finance 70,486
- Business & Industrial 29,085
- Health & Wellness 11,551
- Science & Technology 9,383
- Medical 8,069
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Findings From Long-Term Analysis of the Effects of LYBALVI® (olanzapine and samidorphan) on Negative Symptoms of Schizophrenia Published in The Journal of Clinical Psychiatry
4+ mon, 4+ week ago (866+ words) — 56-Week Post Hoc Analysis Demonstrated Sustained Reduction in Hard-to-Treat Negative Symptoms — The analysis showed decreased negative symptoms over the first four weeks in a pooled analysis of treatment arms (LYBALVI, olanzapine and placebo) in ENLIGHTEN-1 with continued improvement over the…...
Evecxia Doses First Patient in Phase 1b Brain Target Engagement Study of Serotonin Synthesis Amplification Therapy
7+ mon, 4+ day ago (367+ words) RESEARCH TRIANGLE PARK, N.C., February 09, 2026--Evecxia Therapeutics, Inc.—a clinical-stage neuroscience company developing a novel class of Serotonin Synthesis Amplification therapies—today announced that the first patient has been dosed in a Phase 1b randomized, placebo-controlled target-engagement study in patients with depression…...
Johnson & Johnson to highlight breadth of its major depressive disorder portfolio at 2025 ECNP Congress
11+ mon, 3+ day ago (1461+ words) 17 abstracts from across the Company's portfolio and pipeline highlight new clinical and real-world data on major depressive disorder and treatment-resistant depression New post-hoc analysis of CAPLYTA® (lumateperone) Phase 3 data evaluates the impact on sexual function in MDD, reinforcing potential to…...
High psychiatric disorder burden linked to increased dementia risk
11+ mon, 3+ week ago (321+ words) The study collected electronic health records of patients in the psychiatric department of Bicêtre Hospital in France. Oops, something went wrong High psychiatric disorder burden linked to increased dementia risk According to the World Health Organization, over 55 million people have…...